We are live on ! Find out more
BIB icon

ProShares Ultra NASDAQ Biotechnology
BIB

36 hedge funds and large institutions have $18.2M invested in ProShares Ultra NASDAQ Biotechnology in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 6

98% more call options, than puts

Call options by funds: $14.5M | Put options by funds: $7.35M

43% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 7

22% more capital invested

Capital invested by funds: $14.8M → $18.2M (+$3.34M)

20% more funds holding

Funds holding: 30 → 36 (+6)

0.85% less ownership

Funds ownership: 7.55% → 6.7% (-0.85%)

Holders
36
Holders Change
+6
Holders Change %
+20%
% of All Funds
0.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
10
Reduced
7
Closed
6
Calls
$14.5M
Puts
$7.35M
Net Calls
+$7.17M
Net Calls Change
+$3.87M

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$939K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$510K
3
TFA
Toth Financial Advisory
Virginia
+$455K
4
Vontobel Holding
Vontobel Holding
Switzerland
+$386K
5
TSS
Two Sigma Securities
New York
+$215K

Top Sellers

Rank Fund Capital Flow
1
OMC
Old Mission Capital
Illinois
-$1.21M
2
HF
HRT Financial
New York
-$593K
3
Bank Julius Baer & Co
Bank Julius Baer & Co
Switzerland
-$502K
4
UMC
United Maritime Capital
New York
-$175K
5
VFA
Valeo Financial Advisors
Indiana
-$137K
Name Holding Trade Value Shares
Change 		Change in
Stake
CAPTRUST Financial Advisors
26
CAPTRUST Financial Advisors
North Carolina
$18K – – –
MCM
27
MV Capital Management
Maryland
$15K +$13.1K +150 New
WWMSC
28
Wagner Wealth Management (South Carolina)
South Carolina
$10K +$8.73K +100 New
GWM
29
Geneos Wealth Management
Colorado
$9K – – –
AW
30
Avion Wealth
Texas
$6K +$5.41K +62 New
WQ
31
Wealth Quarterback
New Jersey
$5K +$3.84K +44 New
AF
32
Allworth Financial
California
$4K – – –
TCM
33
Tradewinds Capital Management
Washington
$3K +$2.62K +30 New
SL
34
Savior LLC
Massachusetts
$1K -$87 -1 -14%
BWA
35
BDO Wealth Advisors
Florida
$1K – – –
Bank Julius Baer & Co
36
Bank Julius Baer & Co
Switzerland
– -$502K -6,000 Closed
VFA
37
Valeo Financial Advisors
Indiana
– -$137K -1,642 Closed
Simplex Trading
38
Simplex Trading
Illinois
– -$84K -1,016 Closed
DWP
39
Destiny Wealth Partners
Florida
– -$23K -270 Closed
SFS
40
Sowell Financial Services
Arkansas
– -$12K -143 Closed
MLFP
41
MPS Loria Financial Planners
Illinois
– -$8K -100 Closed
Bank of America
42
Bank of America
North Carolina
– +$87 +1 New
1
2

BIB Hedge Fund Activity: Q2 2021 in Review

36 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in ProShares Ultra NASDAQ Biotechnology (BIB) for Q2 2021, worth a combined $18.2M — up 22% from $14.8M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new BIB positions and 6 closed out — a net gain of 6 holders — while 10 added to existing stakes and 7 trimmed.

The largest buyer was Jane Street, opening a new position worth an estimated $939K. The largest seller was Old Mission Capital, cutting an estimated $1.21M.

  • 36 institutional investors held ProShares Ultra NASDAQ Biotechnology (BIB) as of Q2 2021, up from 30 in Q1 2021.
  • Funds reported $18.2M of ProShares Ultra NASDAQ Biotechnology stock for Q2 2021, up 22% quarter-over-quarter.
  • 12 funds opened new ProShares Ultra NASDAQ Biotechnology positions in Q2 2021 and 6 closed out, a net change of +6 holders.
  • The largest ProShares Ultra NASDAQ Biotechnology buyer in Q2 2021 was Jane Street, an estimated $939K added.
  • The largest ProShares Ultra NASDAQ Biotechnology seller in Q2 2021 was Old Mission Capital, an estimated $1.21M sold.

Based on aggregated 13F filings for Q2 2021.